Show simple item record

Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B

dc.contributor.authorKlesezewski, K
dc.contributor.authorApelian, D
dc.contributor.authorFernandes, L
dc.contributor.authorCross, A
dc.contributor.authorWilber, R
dc.contributor.authorShouval, D
dc.contributor.authorSenturk, H
dc.contributor.authorGish, RG
dc.contributor.authorChang, TT
dc.contributor.authorYurdaydin, C
dc.contributor.authorLai, CL
dc.contributor.authorLok, AS
dc.contributor.authorBrown, RS
dc.date.accessioned2021-03-04T12:04:54Z
dc.date.available2021-03-04T12:04:54Z
dc.identifier.citationShouval D., Senturk H., Gish R., Chang T., Yurdaydin C., Lai C., Lok A., Brown R., Apelian D., Fernandes L., et al., "Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B", 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.192
dc.identifier.othervv_1032021
dc.identifier.otherav_759ebb84-50a1-4776-8491-c8496643c551
dc.identifier.urihttp://hdl.handle.net/20.500.12627/80775
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleEntecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume42
dc.contributor.firstauthorID130752


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record